These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3796773)

  • 1. Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea.
    Decaux G; Mols P; Cauchie P; Flamion B; Delwiche F
    Nephron; 1986; 44(4):337-43. PubMed ID: 3796773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urea treatment for water retention in hyponatremic congestive heart failure.
    Cauchie P; Vincken W; Decaux G
    Int J Cardiol; 1987 Oct; 17(1):102-4. PubMed ID: 3666993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors influencing the therapeutic response to diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Ljubicić N; Kujundzić M; Banić M; Vrkljan M
    Scand J Gastroenterol; 1998 Apr; 33(4):441-7. PubMed ID: 9605268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of urea for treatment of water retention in hyponatraemic cirrhosis with ascites resistant to diuretics.
    Decaux G; Mols P; Cauchi P; Delwiche F
    Br Med J (Clin Res Ed); 1985 Jun; 290(6484):1782-3. PubMed ID: 3924252
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin].
    Hagège H; Ink O; Ducreux M; Pelletier G; Buffet C; Etienne JP
    Gastroenterol Clin Biol; 1992; 16(10):751-5. PubMed ID: 1478401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
    Pérez-Ayuso RM; Arroyo V; Planas R; Gaya J; Bory F; Rimola A; Rivera F; Rodés J
    Gastroenterology; 1983 May; 84(5 Pt 1):961-8. PubMed ID: 6339312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.
    Ginès P; Wong F; Watson H; Milutinovic S; del Arbol LR; Olteanu D;
    Hepatology; 2008 Jul; 48(1):204-13. PubMed ID: 18508290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
    Arroyo V; Bosch J; Casamitjana R; Cabrera J; Rivera F; Rodés J
    Gut; 1980 Oct; 21(10):855-9. PubMed ID: 7439805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents.
    Leiva JG; Salgado JM; Estradas J; Torre A; Uribe M
    Ann Hepatol; 2007; 6(4):214-21. PubMed ID: 18007550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema.
    Pockros PJ; Reynolds TB
    Gastroenterology; 1986 Jun; 90(6):1827-33. PubMed ID: 3699402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
    Knauf H; Mutschler E
    Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Factors Predicting the Effect of Tolvaptan for Refractory Ascites in Patients with Decompensated Liver Cirrhosis.
    Chishina H; Hagiwara S; Nishida N; Ueshima K; Sakurai T; Ida H; Minami Y; Takita M; Kono M; Minami T; Iwanishi M; Umehara Y; Watanabe T; Komeda Y; Arizumi T; Kudo M
    Dig Dis; 2016; 34(6):659-664. PubMed ID: 27750234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.
    Fuller RK; Khambatta PB; Gobezie GC
    JAMA; 1977 Mar; 237(10):972-5. PubMed ID: 319263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Diuretic-resistant' ascites. Observations on pathogenesis.
    Rector WG
    Arch Intern Med; 1986 Aug; 146(8):1597-600. PubMed ID: 3729643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Gatta A; Angeli P; Caregaro L; Menon F; Sacerdoti D; Merkel C
    Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study.
    Fiaccadori F; Pedretti G; Pasetti G; Pizzaferri P; Elia G
    Clin Investig; 1993 Jul; 71(7):579-84. PubMed ID: 8374255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of diuretics in the treatment of ascites in patients with cirrhosis].
    Bourgeois N; Devaere S; Adler M; Cremer M
    Acta Gastroenterol Belg; 1990; 53(2):256-60. PubMed ID: 2267905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment of ascites in cirrhosis.
    Gerbes AL
    J Hepatol; 1993; 17 Suppl 2():S4-9. PubMed ID: 8491970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High uric acid and urea clearance in cirrhosis secondary to increased "effective vascular volume".
    Decaux G; Dumont I; Naeije N; Mols P; Melot C; Mockel J
    Am J Med; 1982 Sep; 73(3):328-34. PubMed ID: 7124759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiloride ('MK 870') in patients with ascites due to cirrhosis of the liver.
    Senewiratne B; Sherlock S
    Lancet; 1968 Jan; 1(7534):120-2. PubMed ID: 4169604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.